Dominick DiPaolo By Natalie Morrison 22-Aug-2011 - Last updated on 26-Aug-2011 at 13:32 GMT Facebook Twitter Linkedin Email to a friend DiPaolo has led quality operations at different generic companies including Barr, Wockhardt Pharmaceuticals, and most recently G&W Laboratories. At Tris, he will be in charge of all aspects of quality. Bharatt Chowrira, Addex Pharmaceuticals’ new CEO Jasmine Cui chief scientific officer for PPD Jing-Wen Kuo, chief scientific officer at Anika Therapeutics Mario Rocci, president of Icon development solutions Meghann Smith, senior director of global therapeutic strategic development at Ockham Suzanne Axford-Bryars, project manager at IDEA Dominick DiPaolo, VP of quality at Tris Frederick Lewis as Vice President of Psychiatry and Scientific Affairs at PRA Prev 1 … 4 5 6 7 8 Next